Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06631495

All-cause and Diseases-specific Mortality of High-risk HPV Infection

The corresponding prevention strategies and treatment routes of HPV infection can be provided through investigating causes of death due to HPV infection and specialized diseases.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

HPV Infection Communicable Diseases DNA Virus Infections Disease Attributes Genital Diseases Infections Papillomavirus Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Tumor Virus Infections Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

About this study

Anxiety and panic about HPV infection have become common phenomena in tumor screening. Transitional and useless diagnosis and treatment caused by HPV infection are also common, affecting women's physical and mental health and health economic level. If the investigators can understand the causes of death related to HPV infection and specialized diseases, the investigators can provide corresponding prevention strategies and treatment routes from the level of health policies and individual methods and mechanisms, and also alleviate the related panic caused by HPV infection.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female participate in at least once cervical cancer screening with clear information of HPV DNA test results;
  • Having clear identification (ID number or others) that can be retrieved in the cause of death database.

Exclusion criteria

Cases that do not fully meet all inclusion criteria are used as exclusion criteria.

Treatment and study plan

observation

Other

not available-observation study

Primary outcomes

  1. HR-HPV infection AND all-cause and diseases-specific mortality

    Time frame: one year

    all-cause and diseases-specific mortality of HR-HPV infection

Secondary outcomes

  1. time-period of HR-HPV infection AND all-cause and diseases-specific mortality

    Time frame: one year

    all-cause and diseases-specific mortality of time-period of HR-HPV infection

  2. HR-HPV type AND all-cause and diseases-specific mortality

    Time frame: one year

    all-cause and diseases-specific mortality of HR-HPV type

Study contacts

Contact information is provided by the study sponsor or research team.

Li, doctor

CONTACT

[email protected]

13911988831

Sponsors and collaborators

Lead sponsor

Peking Union Medical College Hospital

Other

Registry information

Important dates

Study start
2024
Primary completion
2026
Study completion
2027
First posted
Oct 8, 2024
Registry last updated
Oct 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.